These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8095440)

  • 1. False-positive results from the Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy.
    Crane T; Dawson CM; Tickner TR
    Clin Chem; 1993 Mar; 39(3):549. PubMed ID: 8095440
    [No Abstract]   [Full Text] [Related]  

  • 2. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Papa P; Rocchi L; Mainardi C; Donzelli G
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-negative results with Emit amphetamine confirmation kit.
    Morland H; Smith-Kielland A
    Clin Chem; 1996 Oct; 42(10):1726-7. PubMed ID: 8855171
    [No Abstract]   [Full Text] [Related]  

  • 4. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay.
    Singh J
    J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839
    [No Abstract]   [Full Text] [Related]  

  • 5. A labetalol metabolite with analytical characteristics resembling amphetamines.
    Gilbert RB; Peng PI; Wong D
    J Anal Toxicol; 1995; 19(2):84-6. PubMed ID: 7769792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unavailability of drug metabolite reference material to evaluate false-positive results for monoclonal EMIT-d.a.u. assay of amphetamine.
    Poklis A
    Clin Chem; 1992 Dec; 38(12):2560. PubMed ID: 1458603
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
    Verstraete AG; Heyden FV
    J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.
    Baker DP; Murphy MS; Shepp PF; Royo VR; Caldarone ME; Escoto B; Salamone SJ
    J Forensic Sci; 1995 Jan; 40(1):108-12. PubMed ID: 7876791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay.
    Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K
    Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW; Manno JE; Cockerham KR; Manno BR
    J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH].
    Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement.
    Nakanishi K; Miki A; Zaitsu K; Kamata H; Shima N; Kamata T; Katagi M; Tatsuno M; Tsuchihashi H; Suzuki K
    Forensic Sci Int; 2012 Apr; 217(1-3):174-81. PubMed ID: 22154438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Reports of Aripiprazole Causing False-Positive Urine Amphetamine Drug Screens in Children.
    Kaplan J; Shah P; Faley B; Siegel ME
    Pediatrics; 2015 Dec; 136(6):e1625-8. PubMed ID: 26527556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole causing false positive urine amphetamine drug screen in an adult patient with bipolar disorder.
    Caricasole V; Spagnolo G; Di Bernardo I; Cirnigliaro G; Piccoli E; Dell'Osso B
    Compr Psychiatry; 2019 Oct; 94():152126. PubMed ID: 31518847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive results with Emit II amphetamine/methamphetamine assay in users of common psychotropic drugs.
    Smith-Kielland A; Olsen KM; Christophersen AS
    Clin Chem; 1995 Jun; 41(6 Pt 1):951-2. PubMed ID: 7768025
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.
    Caravati EM; Juenke JM; Crouch BI; Anderson KT
    Ann Pharmacother; 2005 Sep; 39(9):1446-9. PubMed ID: 16046487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine/methamphetamine assay.
    Grinstead GF
    Clin Chem; 1989 Sep; 35(9):1998-9. PubMed ID: 2673588
    [No Abstract]   [Full Text] [Related]  

  • 19. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens.
    Piergies AA; Sainati S; Roth-Schechter B
    Arch Pathol Lab Med; 1997 Apr; 121(4):392-4. PubMed ID: 9140309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.